BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 12610409)

  • 1. [Should associated intraoperative and/or postoperative photocoagulation be systematic during or after vitrectomy for proliferative diabetic vitreoretinopathy?].
    Hajji Z; Rouillot JS; Roth P; Grange JD
    J Fr Ophtalmol; 2003 Jan; 26(1):47-53. PubMed ID: 12610409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of vitrectomy combined with full endocular panretinal photocoagulation in late proliferative diabetic retinopathy].
    Zhang SC; Gao RL; Ding XY; Li CF; Liu T
    Zhonghua Yan Ke Za Zhi; 2003 Dec; 39(12):740-2. PubMed ID: 14769226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neovascular glaucoma following pars plana vitrectomy for complications of diabetic retinopathy.
    Wand M; Madigan JC; Gaudio AR; Sorokanich S
    Ophthalmic Surg; 1990 Feb; 21(2):113-8. PubMed ID: 2330190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pars plana lensectomy, pars plana vitrectomy, and silicone oil tamponade as initial management of cataract and combined traction/rhegmatogenous retinal detachment involving the macula associated with severe proliferative diabetic retinopathy.
    Douglas MJ; Scott IU; Flynn HW
    Ophthalmic Surg Lasers Imaging; 2003; 34(4):270-8. PubMed ID: 12875454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
    Wilczyński M; Dzivgielewski K
    Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and complications of 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
    Ozone D; Hirano Y; Ueda J; Yasukawa T; Yoshida M; Ogura Y
    Ophthalmologica; 2011; 226(2):76-80. PubMed ID: 21613797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postoperative proliferative vitreoretinopathy in rhegmatogenous retinal detachment associated with stage B preoperative proliferative vitreoretinopathy: comparative results of trans-scleral retinopexy with diode laser or trans-pupillary retinopexy with argon laser].
    Duquesne N; Fleury J; Bonnet M
    J Fr Ophtalmol; 1998 Oct; 21(8):555-9. PubMed ID: 9833220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy.
    Luttrull JK; Musch DC; Spink CA
    Eye (Lond); 2008 May; 22(5):607-12. PubMed ID: 17293791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The predictive value of a classification for proliferative diabetic vitreoretinopathy].
    Hesse L; Heller G; Kraushaar N; Wesp A; Schroeder B; Kroll P
    Klin Monbl Augenheilkd; 2002; 219(1-2):46-9. PubMed ID: 11932810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema.
    Kumagai K; Furukawa M; Ogino N; Larson E; Iwaki M; Tachi N
    Retina; 2009 Apr; 29(4):464-72. PubMed ID: 19289987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vitrectomy in proliferative diabetic retinopathy. Preoperative factors for surgical procedure and postoperative results].
    Ulbig M; Kampik A; Heidenkummer HP
    Fortschr Ophthalmol; 1990; 87(5):443-8. PubMed ID: 2272571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of liquid perfluorocarbons in vitrectomy for difficult cases of proliferative diabetic retinopathy].
    Le Mer Y
    J Fr Ophtalmol; 1995; 18(5):366-72. PubMed ID: 7560772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. En bloc perfluorodissection for tractional retinal detachment in proliferative diabetic retinopathy.
    Arevalo JF
    Ophthalmology; 2008 Jun; 115(6):e21-5. PubMed ID: 18423870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vitrectomy and proliferative diabetic retinopathy. Apropos of 66 eyes].
    Bouchard O; Zech JC; Trepsat C
    J Fr Ophtalmol; 1997; 20(4):263-70. PubMed ID: 9181137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pars plana vitrectomy for proliferative diabetic vitreoretinopathy on preexisting diabetic maculopathy.
    Hoerle S; Poestgens H; Schmidt J; Kroll P
    Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):197-201. PubMed ID: 11935276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endolaser photocoagulation in vitrectomy surgery].
    Zhao P; Wang W; Chen Q
    Zhonghua Yan Ke Za Zhi; 1996 Mar; 32(2):123-5. PubMed ID: 9206229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vitrectomy and subsequent photocoagulation in proliferative diabetic retinopathy with vitreous hemorrhage].
    Gerke E; Alvira G
    Klin Monbl Augenheilkd; 1986 Jan; 188(1):5-8. PubMed ID: 2421045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vitrectomy with peeling retinal limiting membrane (ILM) in eyes with diabetic macular edema].
    Oficjalska-Młyńczak J; Jamrozy-Witkowska A; Muzyka-Woźniak M; Turno-Krecicka A; Gołebiowska B
    Klin Oczna; 2006; 108(7-9):273-7. PubMed ID: 17290822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of transconjunctival sutureless 25-gauge vitrectomy with silicone oil infusion.
    Riemann CD; Miller DM; Foster RE; Petersen MR
    Retina; 2007 Mar; 27(3):296-303. PubMed ID: 17460584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.